Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alloway

Showing results (71-80 of 164) with videos related to

Pageof 17
Sort By:
Transplantation Proceedings|April 26, 2005
Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppressionC C Rogers, R R Alloway, M Hanaway, et al.
Plastic and Reconstructive Surgery|August 19, 2007
Risk assessment of immunosuppressive therapy in facial transplantationDalibor Vasilic, Rita R Alloway, John H Barker, et al.
MDM Policy & Practice|November 4, 2021
Incorporating Patients' Values and Preferences Into Decision Making About Transplantation of HCV-Naïve Recipients With Kidneys From HCV-Viremic Donors: A Feasibility StudyMark H Eckman, Adeboye A Adejare, Heather Duncan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2011
Evolution of the role of the transplant pharmacist on the multidisciplinary transplant teamR R Alloway, R Dupuis, S Gabardi, et al.
Transplantation|May 9, 2009
De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general populationYun Miao, Jason J Everly, Thomas G Gross, et al.
Annals of Transplantation|October 14, 2004
Donor transmitted malignanciesJoseph F Buell, Thomas M Beebe, Jennifer Trofe, et al.
Kidney International|February 1, 1996
Correlation between Banff classification, acute renal rejection scores and reversal of rejectionL W Gaber, L W Moore, R R Alloway, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 26, 2013
Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney transplant recipientsN S Ejaz, A R Shields, R R Alloway, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|July 22, 2004
Polyomavirus nephropathy in kidney transplantationJennifer Trofe, Jennifer Gordon, Prabir Roy-Chaudhury, et al.
Transplantation|March 12, 2025
Phase 2, Randomized, Double-blind, Placebo-controlled Study of Fiztasovimab (NPC-21) for Kidney Transplant Recipients at High Risk of Cytomegalovirus Infection (LionHeart21)Naotsugu Ichimaru, Yoichiro Natori, Rita R Alloway, et al.
Pageof 17

Showing results (71-80 of 164) with videos related to

Sort By:
Pageof 17
Transplantation Proceedings|April 26, 2005
Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppressionC C Rogers, R R Alloway, M Hanaway, et al.
Plastic and Reconstructive Surgery|August 19, 2007
Risk assessment of immunosuppressive therapy in facial transplantationDalibor Vasilic, Rita R Alloway, John H Barker, et al.
MDM Policy & Practice|November 4, 2021
Incorporating Patients' Values and Preferences Into Decision Making About Transplantation of HCV-Naïve Recipients With Kidneys From HCV-Viremic Donors: A Feasibility StudyMark H Eckman, Adeboye A Adejare, Heather Duncan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2011
Evolution of the role of the transplant pharmacist on the multidisciplinary transplant teamR R Alloway, R Dupuis, S Gabardi, et al.
Transplantation|May 9, 2009
De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general populationYun Miao, Jason J Everly, Thomas G Gross, et al.
Annals of Transplantation|October 14, 2004
Donor transmitted malignanciesJoseph F Buell, Thomas M Beebe, Jennifer Trofe, et al.
Kidney International|February 1, 1996
Correlation between Banff classification, acute renal rejection scores and reversal of rejectionL W Gaber, L W Moore, R R Alloway, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 26, 2013
Randomized controlled pilot study of B cell-targeted induction therapy in HLA sensitized kidney transplant recipientsN S Ejaz, A R Shields, R R Alloway, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|July 22, 2004
Polyomavirus nephropathy in kidney transplantationJennifer Trofe, Jennifer Gordon, Prabir Roy-Chaudhury, et al.
Transplantation|March 12, 2025
Phase 2, Randomized, Double-blind, Placebo-controlled Study of Fiztasovimab (NPC-21) for Kidney Transplant Recipients at High Risk of Cytomegalovirus Infection (LionHeart21)Naotsugu Ichimaru, Yoichiro Natori, Rita R Alloway, et al.
Pageof 17